| Nom du produit | Pramiracetam |
| Numéro CAS | 68497-62-1 |
| Formule moléculaire | C₁₄H₂₇N₃O₂ |
| Poids moléculaire | 269.38 g/mol |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | ≥ 99,01 TP3T |
| Point de fusion | 122–126°C |
| Perte au séchage | ≤ 0,5% |
| Résidu au feu | ≤ 0,11 TP3T |
| Métaux lourds | ≤ 10 ppm |
Besoin d'aide ? Contacter notre équipe
Pramiracetam is a potent nootropic compound belonging to the racetam family, structurally related to piracetam but significantly more powerful. It was developed by Warner-Lambert and is known for its pronounced memory-enhancing and cognitive-supporting properties.
PraMistar
Pramiracetam is approximately 10–30 times more potent than piracetam on a milligram-to-milligram basis. It is one of the most lipid-soluble racetams, resulting in high central nervous system bioavailability.
Synonymes :
Amacétam
NeupraMir
PraMistar
ReMen
Vinpotropil
N-[2-(Diisopropylamino)ethyl]-2-oxo-1-pyrrolidineacetamide
| Parcours | Effet | Clinical Relevance |
|---|---|---|
| High-affinity choline uptake (HACU) enhancement | Increases choline transport into neurons | Supports acetylcholine synthesis |
| AMPA receptor modulation | Positive allosteric modulation | Enhances glutamate-mediated neurotransmission |
| Acetylcholine release enhancement | Increases evoked ACh release in hippocampus | Memory formation and consolidation |
| Long-term potentiation (LTP) facilitation | Enhances synaptic plasticity | Learning and memory retention |
LyvBio Co. is a supplier of high-purity Pramiracetam for the nutraceutical and nootropic industries.
Capacités d'approvisionnement :
La pureté : ≥99,01 % TP3T (HPLC)
Capacité mensuelle : plus de 500 kg
Quantités en vrac : 100 g – 5 000 kg
Délai d'exécution : 3-5 jours (échantillons), 10-15 jours (vrac)
Documentation : COA, MSDS,HNMr, HPLC chromatogram, stability data
Certifications disponibles :
GMP / ISO 2000
📧 Demandes de renseignements : info@lyvbio.com
| Paramètre | Spécifications | Méthode d'essai |
|---|---|---|
| Essai (HPLC) | ≥ 99,01 TP3T | HPLC-UV |
| Apparence | Poudre cristalline blanche à blanc cassé | Visuel |
| Identification | Temps de rétention HPLC, IR | HPLC/IR |
| Point de fusion | 122–126°C | USP |
| Perte au séchage | ≤ 0,5% | USP |
| Résidu au feu | ≤ 0,11 TP3T | USP |
| Métaux lourds | ≤ 10 ppm | ICP-MS |
| Substances apparentées | Single impurity ≤ 0.2%; Total ≤ 1.0% | HPLC-UV |
| Solvants résiduels | Découvrez la norme USP | GC |
| Combination | Effet | Idéal pour |
|---|---|---|
| Pramiracetam + Alpha-GPC | Choline source + HACU enhancement | Complete cholinergic support |
| Pramiracetam + Piracetam | Potent + baseline racetam | Broad cognitive enhancement |
| Pramiracetam + Aniracetam | HACU + AMPA + anxiolytic | Memory + anxiety reduction |
| Pramiracetam + Noopept | HACU + AMPA/BDNF | Potent memory + neuroprotection |
| Pramiracetam + Phosphatidylserine | Cholinergic + membrane support | Age-related cognitive decline |
Mots-clés : Pramiracetam CAS 68497-62-1, high-potency nootropic, memory enhancement ingredient, racetam family, cognitive support raw material, HACU enhancer, nootropic stack ingredient, LyvBio Pramiracetam
📧 Courriel : info@lyvbio.com
🌐 Site web : https://www.lyvbio.com
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese